Power Law company profile

CytomX Therapeutics

Biotech & Life Sciences · South San Francisco, United States · Founded 2008 · IPO 2015 Thoroughbred

Early-stage biotechnology company developing probodies, proteolytically-activated antibodies

Valuation

$777M

Market cap · May/2026

Revenue

$76M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

7 investors on CytomX Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

Pfizer Ventures

Third Rock Ventures

Roche Venture Fund

Tech Coast Angels

Canaan

Mike Panesis

BVF Partners

CytomX Therapeutics mafia

Startups founded by CytomX Therapeutics alumni

Former CytomX Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.

R1 TherapeuticsEst. 2025

Krishna PoluUnited States

Signal score83

True North TherapeuticsEst. 2013

NSNancy StaglianoUnited States

Signal score60

SerImmuneEst. 2014

Patrick DaughertyUnited States

Signal score59

EvolveImmune TherapeuticsEst. 2019

Charles FuchsUnited States

Signal score55

Book a demo to explore the full alumni network →

Global footprint

Where CytomX Therapeutics has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

27K monthly visits
across markets

🇺🇸 United States76.3%

🇬🇧 United Kingdom6.3%

🇮🇳 India5.6%

🇯🇵 Japan5.2%

🇫🇷 France4.1%

Top 5 markets shown

Market sentiment

What the market is saying about CytomX Therapeutics

An AI-synthesized read of the highest-engagement posts about CytomX Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CytomX Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles